Cipla Medpro Gets $32.6 Million To Supply S. Africa Respiratory Drugs
This article was originally published in PharmAsia News
Executive Summary
Cipla Medpro has received a $32.6 million share of South Africa's purchases of respiratory drugs as the nation battles a high mortality rate from asthma.